company background image
C1CO34 logo

Cencora BOVESPA:C1CO34 Stock Report

Last Price

R$695.00

Market Cap

R$271.5b

7D

-2.3%

1Y

40.4%

Updated

28 Dec, 2024

Data

Company Financials +

Cencora, Inc.

BOVESPA:C1CO34 Stock Report

Market Cap: R$271.5b

C1CO34 Stock Overview

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. More details

C1CO34 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth3/6
Past Performance1/6
Financial Health3/6
Dividends0/6

Rewards

Trading at 48.6% below our estimate of its fair value

Earnings are forecast to grow 14.79% per year

Risk Analysis

Shares are highly illiquid

Has a high level of debt

Large one-off items impacting financial results


My Notes

Capture your thoughts, links and company narrative

Cencora, Inc. Competitors

Rede D'Or São Luiz

BOVESPA:RDOR3

R$57.6b

Profarma Distribuidora de Produtos Farmacêuticos

BOVESPA:PFRM3

R$756.5m

Cardinal Health

NYSE:CAH

US$28.8b

McKesson

NYSE:MCK

US$73.4b

Price History & Performance

Summary of share price highs, lows and changes for Cencora
Historical stock prices
Current Share PriceUS$695.00
52 Week HighUS$758.00
52 Week LowUS$510.30
Beta0.46
1 Month Change-3.08%
3 Month Changen/a
1 Year Change40.40%
3 Year Change92.70%
5 Year Changen/a
Change since IPO276.29%

Recent News & Updates

Recent updates

Shareholder Returns

C1CO34BR HealthcareBR Market
7D-2.3%-5.2%-2.2%
1Y40.4%-32.9%-14.8%

Return vs Industry: C1CO34 exceeded the BR Healthcare industry which returned -32.9% over the past year.

Return vs Market: C1CO34 exceeded the BR Market which returned -14.8% over the past year.

Price Volatility

Is C1CO34's price volatile compared to industry and market?
C1CO34 volatility
C1CO34 Average Weekly Movementn/a
Healthcare Industry Average Movement7.5%
Market Average Movement5.1%
10% most volatile stocks in BR Market9.7%
10% least volatile stocks in BR Market3.0%

Stable Share Price: C1CO34's share price has been volatile over the past 3 months compared to the BR market.

Volatility Over Time: Insufficient data to determine C1CO34's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
187144,000Bob Mauchwww.cencora.com

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company’s U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.

Cencora, Inc. Fundamentals Summary

How do Cencora's earnings and revenue compare to its market cap?
C1CO34 fundamental statistics
Market capR$271.50b
Earnings (TTM)R$9.34b
Revenue (TTM)R$1.82t

29.1x

P/E Ratio

0.1x

P/S Ratio

Is C1CO34 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
C1CO34 income statement (TTM)
RevenueUS$293.96b
Cost of RevenueUS$284.17b
Gross ProfitUS$9.79b
Other ExpensesUS$8.28b
EarningsUS$1.51b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)7.81
Gross Margin3.33%
Net Profit Margin0.51%
Debt/Equity Ratio557.8%

How did C1CO34 perform over the long term?

See historical performance and comparison

Dividends

1.0%

Current Dividend Yield

27%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/28 00:16
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Cencora, Inc. is covered by 39 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David ToungArgus Research Company
Gregory BolanAvondale Partners
Eric ColdwellBaird